Das Lee Silverman Voice Treatment (LSVT)

Zusammenfassung

Das Lee Silverman Voice Treatment (LSVT) ist ein in Deutschland noch recht unbekanntes intensives Therapiekonzept, das speziell zur Behandlung der Sprech- und Stimmproblematik bei M. Parkinson entwickelt wurde. Behandlungsfokus liegt auf der Stimme und vor allem auf einer erhöhten Sprechlautstärke, die als Trigger für Kraft und Koordination in allen Subsystemen des Sprechens fungiert, so dass sich neben der Stimmfunktion auch unter anderem Verständlichkeit und Schlucksymptomatik nachweisbar verbessern. Um den Therapietransfer in die Alltagssprache zu stabilisieren, findet ein sensorisches Wahrnehmungstraining in Bezug auf Krafteinsatz und Lautstärke besondere Berücksichtigung. LSVT ist bei Parkinsonpatienten die erste Sprechtherapie, deren Wirksamkeit durch zahlreiche Kurz- und Langzeitstudien eindrucksvoll belegt ist.

Summary

The Lee Silverman Voice Treatment (LSVT) is an intensive treatment program for individuals with Parkinson’s disease (PD) and in Germany still quite unknown. Focus is on voice and specially on increased loudness, that triggers effort and coordination across all speech mechanisms. Beside improvement of voice function, there is evidence of improved intelligibility and swallowing. It also addresses increased sensory perception of vocal effort and loudness to facilitate carry-over into daily oral communication. LSVT has been extensively documented in the short and long term with the first level-one efficacy data for successfully treating voice and speech disorders in PD.

Schlüsselwörter

Lee Silverman Voice Treatment - Dysarthrophonie - evidenzbasierte - Stimmtherapie - Lautstärke

Keywords

Lee Silverman Voice Treatment - dysarthria - evidence based voice treatment - loudness

• Literatur

• 1 Aronson A. Clinical voice disorders. New York: Thieme-Stratton; 1990
• 2 Benecke P. Lee Silverman Voice Treatment: Intensives Stimmtraining für Parkinson-Patienten. Forum Logop 1999; 1: 26-8.
• 3 Countryman S, Ramig L, Pawlas A. Speech and voice deficits in Parkinsonian Plus syndromes: Can they be treated?. J Med Speech Pathol 1994; 2: 211-25.
• 4 Dromey C, Ramig L. Intentional changes in sound pressure level and rate: Their impact on measures of respiration, phonation and artikulation. J Speech Lang Hear Res 1998; 41: 1003-18.
• 5 El-Sharkawi A, Ramig L, Logemann J. et al. Swallowing and voice effects of Lee Silverman Voice Treatment: A pilot study. J Neurol Neurosurg Psychiatry 2002; 72: 31-6.
• 6 Erdmann S. Neue Ansätze in der Sprachtherapie bei der Parkinson’s chen Erkrankung. Logos Interdisziplinär 2002; 3: 180-5.
• 7 Fox C, Morrison C, Ramig L. Current perspectives on the Lee Silverman Voice Treatment (LSVT®). Am J Speech Lang Pathol 2002; 11: 111-23.
• 8 Fox C, Ramig L. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol 1997; 6: 85-94.
• 9 Ho AK, Jansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol 1998; 11: 131-7.
• 10 Liotti M, Vogel D, Ramig L, New P, Cook C, Fox P. Functional reorganization of speech-motor function in Parkinson disease following LSVT: A PET study. Neurology 2003; 60: 432-40.
• 11 Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and concurrence of vocal tract dysfunktions in the speech of a large sample of Parkinson patients. J Speech Hearing Disord 1987; 42: 47-57.
• 12 Ramig L. The role of phonation in speech intelligibility: a review and preliminary data from patients with Parkinson’s disease. In: Kent RD. (ed) Intelligibility in Speech Disorders: Theory, Measurement and Management. Amsterdam: John Benjamin; 1992
• 13 Ramig L, Bonitati CM, Lemke JH, Horii Y. Voice treatment for patients with Parkinson disease: Development of an approach and preliminary efficacy data. J Med Speech-Lang Pathol 1994; 2: 191-209.
• 14 Ramig L, Countryman S, Thompson L, Horii Y. A comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hearing Res 1995; 38: 1232-51.
• 15 Ramig L, Pawlas A, Countryman S. The Lee Silverman Voice Treatment (LSVT®): A practical guide to treating the voice and speech disorders in Parkinson Disease. Iowa City, IA: National Center for Voice and Speech; 1995
• 16 Ramig L, Countryman S, O’Brien C, Hoehn M, Thompson L. Intensive speech treatment for patients with Parkinson disease: Short and longterm comparison of two techniques. Neurology 1996; 47: 1496-1504.
• 17 Ramig L, Dromey C. Aerodynamic mechanisms underlying treatment related changes in SPL in patients with Parkinson disease. J Speech Hear Res 1996; 39: 798-807.
• 18 Ramig L, Verdolini K. Treatment efficacy: Voice disorders. J Speech Lang Hear Res 1998; 41: 101-16.
• 19 Ramig LO, Fox C, Sapir S. Parkinson’s Disease: Speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang 2004; 25: 169-80.
• 20 Robertson SJ, Thomson F. Speech therapy in Parkinson’s disease. A study of the efficacy and long term effects of intensive treatment. Br J Disord Commun 1984; 19: 213-24.
• 21 Sapir S, Pawlas A, Rami L, Seeley E, Fox C, Corboy J. Effects of intensive phonatory-respiratory treatment (LSVTÒ) on voice in two individuals with multiple sclerosis. J Med Speech-Lang Pathol 2001; 9: 35-45.
• 22 Sapir S, Ramig L, Hoyt P. O’Brien Hoehn M. Speech loudness and qualitiy 12 months after intensive voice treatment (LSVT) for Parkinson’s disease: a comparison with an alternative speech treatment. Folia Phoniatr 2002; 54: 296-303.
• 23 Sapir S, Spielman J, Ramig L. et al. Effects of intensive voice treatment (the Lee Silverman Voice Treatment, LSVTÒ) on ataxic dysarthria: A case study. Am J Speech Lang Pathol 2003; 12: 387-99.
• 24 Smith M, Ramig L. Neurologic disorders and the voice. In: Gould W, Rubin JS, Korovin G, Sataloff R. (eds) Diagnosis and Treatment of Voice Disorders. New York, Tokyo: Igaku-Shoin; 1995
• 25 Smith ME, Ramig L, Dromey C, Perez KS, Samandari R. Intensive voice treatment in Parkinson’s disease: Laryngostroboscopic findings. J Voice 1995; 9: 453-9.
• 26 Spiecker-Henke M. Leitlinien der Stimmtherapie. Stuttgart: Thieme; 1997
• 27 Spielman J, Borod J, Ramig L. The effects of intensive voice treatment (LSVT®) on facial expressiveness in Parkinson’s disease. Cogn Behav Neurol 2003; 16: 177-88.
• 28 Vieregge P, Dethlefsen J. Krankengymnastik und Logopädie beim Parkinson-Syndrom – eine Bestandsaufnahme. Fortschr Neurol Psychiatr 1992; 60: 369-74.
• 29 Ziegler W, Vogel M, Gröne B. et al. Dysarthrie. Grundlagen-Diagnostik-Therapie. Stuttgart: Thieme; 1998